Tootsie Roll Industries (TR) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
8 Aug, 2025Executive summary
Net product sales rose 2.9% to $153.2M in Q2 2025 year-over-year, with net earnings up 12.2% to $17.5M and EPS up 14.3% to $0.24, while H1 sales dipped 0.2% to $299.7M but net earnings increased 13.1% to $35.6M and EPS rose 14.0% to $0.49.
Adjusted operating earnings grew 28.2% in Q2 and 16.8% in H1 2025, driven by improved gross margins and cost controls.
Higher Q2 sales attributed to successful marketing and sales programs, while H1 faced resistance to price increases.
Share repurchases reduced shares outstanding, boosting EPS.
Financial highlights
Q2 2025 total revenue: $155.1M; H1 2025: $303.5M.
Q2 gross margin improved to $56.5M from $50.5M year-over-year; H1 gross margin rose to $108.9M from $100.5M.
Adjusted product cost of goods sold as % of sales decreased to 63.8% in Q2 2025 from 66.9% in Q2 2024.
Other income, net, was $14.1M in Q2 2025, up from $4.9M in Q2 2024, reflecting higher investment income and insurance recovery.
EPS for Q2 2025: $0.24 vs. $0.21; H1 2025: $0.49 vs. $0.43.
Outlook and guidance
Management expects higher cocoa and chocolate costs to pressure margins in H2 2025 and 2026 as new supply contracts at elevated prices take effect.
Company remains cautious about passing on further cost increases to customers due to consumer resistance.
Plant expansion planned over five years, with $95M–$100M in capital expenditures, mostly in 2026–2027, funded by internal cash flow.
Ongoing investments in manufacturing to meet demand and improve efficiencies.
Latest events from Tootsie Roll Industries
- Net earnings and margins declined in Q2 2026 as higher costs and promotions pressured results.TR
Q2 2026 - Net sales rose 2% to $149.5M, but higher costs and taxes reduced net earnings to $17.7M.TR
Q1 2026 - Proxy covers director elections, auditor ratification, and executive pay, with strong governance.TR
Proxy filing - 2025 earnings rose on higher sales and margin recovery, with input costs and tariffs easing ahead.TR
Q4 2025 - Annual meeting to elect directors and ratify auditor, with board oversight and controlled voting.TR
Proxy Filing - Q3 2025 saw higher sales, earnings, and margins, but input costs and tariffs remain risks.TR
Q3 2025 - Q3 sales fell nearly 10%, but margins and EPS improved; cocoa costs and pension risks persist.TR
Q3 2024 - Earnings and EPS rose despite lower sales, but margin pressure from high cocoa costs is expected.TR
Q2 2024 - Earnings rose 14% despite lower sales, but margin pressure from cocoa costs is expected ahead.TR
Q1 2025